M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) CHEMOTHERAPY FOR TRANSITIONAL CELL-CARCINOMA - THE PRINCESS-MARGARET-HOSPITAL EXPERIENCE

被引：121

作者：

TANNOCK, I

GOSPODAROWICZ, M

CONNOLLY, J

JEWETT, M

机构：

[1] PRINCESS MARGARET HOSP,DEPT RADIAT ONCOL,TORONTO M4X 1K9,ONTARIO,CANADA

[2] UNIV TORONTO,DEPT SURG,DIV UROL,TORONTO M5S 1A1,ONTARIO,CANADA

来源：

JOURNAL OF UROLOGY | 1989年 / 142卷 / 02期

关键词：

D O I：

10.1016/S0022-5347(17)38733-5

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：289 / 292

页数：4

共 12 条

[1]

HILLCOAT B L, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P110

[2] COMPARATIVE ACTIVITY AND TOXICITY OF CIS-DIAMMINEDICHLOROPLATINUM (DDP) AND A COMBINATION OF DOXORUBICIN, CYCLOPHOSPHAMIDE, AND DDP IN DISSEMINATED TRANSITIONAL CELL CARCINOMAS OF THE URINARY-TRACT [J].

KHANDEKAR, JD ;

ELSON, PJ ;

DEWYS, WD ;

SLAYTON, RE ;

HARRIS, DT .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (04) :539-545

[3] THE THROMBOGENIC EFFECT OF ANTICANCER DRUG-THERAPY IN WOMEN WITH STAGE-II BREAST-CANCER [J].

LEVINE, MN ;

GENT, M ;

HIRSH, J ;

ARNOLD, A ;

GOODYEAR, MD ;

HRYNIUK, W ;

DEPAUW, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (07) :404-407

[4] NEOADJUVANT M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) EFFECT ON THE PRIMARY BLADDER LESION [J].

SCHER, HI ;

YAGODA, A ;

HERR, HW ;

STERNBERG, CN ;

BOSL, G ;

MORSE, MJ ;

SOGANI, PC ;

WATSON, RC ;

DERSHAW, DD ;

REUTER, V ;

GELLER, N ;

HOLLANDER, PS ;

VAUGHAN, ED ;

WHITMORE, WF ;

FAIR, WR .

JOURNAL OF UROLOGY, 1988, 139 (03) :470-474

[5]

SOLOWAY MS, 1983, CANCER, V52, P767, DOI 10.1002/1097-0142(19830901)52:5<767::AID-CNCR2820520502>3.0.CO

[6]

2-P

[7] PRELIMINARY-RESULTS OF M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) FOR TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM [J].

STERNBERG, CN ;

YAGODA, A ;

SCHER, HI ;

WATSON, RC ;

AHMED, T ;

WEISELBERG, LR ;

GELLER, N ;

HOLLANDER, PS ;

HERR, HW ;

SOGANI, PC ;

MORSE, MJ ;

WHITMORE, WF .

JOURNAL OF UROLOGY, 1985, 133 (03) :403-407

[8] M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) FOR ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM [J].

STERNBERG, CN ;

YAGODA, A ;

SCHER, HI ;

WATSON, RC ;

HERR, HW ;

MORSE, MJ ;

SOGANI, PC ;

VAUGHAN, ED ;

BANDER, N ;

WEISELBERG, LR ;

GELLER, N ;

HOLLANDER, PS ;

LIPPERMAN, R ;

FAIR, WR ;

WHITMORE, WF .

JOURNAL OF UROLOGY, 1988, 139 (03) :461-469

[9] LACK OF EVIDENCE FOR A ROLE OF CHEMOTHERAPY IN THE ROUTINE MANAGEMENT OF LOCALLY ADVANCED HEAD AND NECK-CANCER [J].

TANNOCK, IF ;

BROWMAN, G .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (07) :1121-1126

[10]

TANNOCK IF, 1983, CANCER, V51, P216, DOI 10.1002/1097-0142(19830115)51:2<216::AID-CNCR2820510208>3.0.CO

← 1 2 →